Home / Inspections / 1294814

FDA Inspection 1294814 — Corden Pharma Colorado, Inc.

Corden Pharma Colorado, Inc. — FEI 1710165

The FDA completed an inspection of Corden Pharma Colorado, Inc. on November 14, 2025 in Boulder, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 14, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boulder, CO (United States)

Facility

Other inspections at this facility

  • 1081516 (VAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1052209 (NAI Fri Mar 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988484 (VAI Mon May 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 977464 (NAI Fri Feb 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 840164 (VAI Fri Jun 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources